Treatment Registry
TR-0361 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Tonik · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$349

Medication · Monthly, month-to-month$349

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly, month-to-month

Monthly $349 per month Month-to-month access

source

Per month$349Charged today$349
Quarterly

Quarterly $249 per month $747 billed every 3 months

source

Per month$249Charged today$747
Annually

Annually $229 per month $2,748 billed yearly

source

Per month$229Charged today$2,748
Visit Tonik

We earn nothing from this link. Tonik has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyStrive Pharmacy; Olympia Pharmacy
PrescriberLive visit
Cancellation“Subscriptions may be canceled any time before the next billing date , subject to the minimum commitment below. ... You may request cancellation at any time, but your cancellation will not become effective until after the initial 3-month subscription period has been completed.”

Not yet checked: states, membership and consult fee.

Recorded from tonikwellness.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026All plans are all-inclusive ('INCLUDES: Semaglutide/Tirzepatide, Injection supplies, Provider oversight, Concierge support, Secure patient portal') with no separate membership fee. The Semaglutide product detail page (/product/semaglutide) showed 'This product is out of stock.' at the time of check even though it still listed 'As low as $149.00/month'.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0361
Readings
1

Related records

What else Tonik sells

All Tonik programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Tonik compounded tirzepatide (TR-0361). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0361

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.